Related Experiment Videos
[Severe bronchospasm in a 1-year old child treated with halothane]
T G Hansen1, C M Pedersen, H Lybecker
1Odense Sygehus, anaestesi- og intensivafdeling V.
Ugeskrift for Laeger
|January 3, 1994
Insights
Severe bronchospasm in an infant was treated successfully with halothane inhalation when conventional therapies failed. This case highlights halothane
Area of Science:
- Pediatric Critical Care Medicine
- Anesthesiology
Background:
- Severe bronchospasm poses a significant challenge in mechanically ventilated infants.
- Conventional bronchodilatory treatments have variable efficacy in pediatric cases.
Observation:
- A one-year-old mechanically ventilated girl experienced severe bronchospasm.
- Maximal conventional bronchodilatory treatments were ineffective.
Findings:
- Halothane inhalation provided a unique and effective bronchodilatory response.
- The case demonstrates a potential alternative for refractory bronchospasm.
Implications:
- Halothane may be considered as a rescue therapy for severe, refractory bronchospasm in infants.
- Further research is warranted to establish the safety and efficacy profile of halothane in this context.
Abstract:
A case of severe bronchospasm in a one-year old mechanically ventilated girl which in spite of maximal conventional bronchodilatory treatment only responded to halothane inhalation is presented. The benefits and limitations of this therapy are discussed.